HEADER MEMBRANE PROTEIN 15-AUG-22 8AR2 TITLE SOLUTION STRUCTURE OF TLR5 TRANSMEMBRANE AND CYTOPLASMIC JUXTAMEMBRANE TITLE 2 REGIONS COMPND MOL_ID: 1; COMPND 2 MOLECULE: TOLL-LIKE RECEPTOR 5; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: TOLL/INTERLEUKIN-1 RECEPTOR-LIKE PROTEIN 3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TLR5, TIL3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR A.V.SHABALKINA,F.D.KORNILOV,M.V.GONCHARUK,S.A.GONCHARUK,A.S.ARSENIEV, AUTHOR 2 K.S.MINEEV REVDAT 3 19-JUN-24 8AR2 1 REMARK REVDAT 2 29-MAR-23 8AR2 1 JRNL REVDAT 1 22-MAR-23 8AR2 0 JRNL AUTH F.D.KORNILOV,A.V.SHABALKINA,C.LIN,P.E.VOLYNSKY,E.F.KOT, JRNL AUTH 2 A.L.KAYUSHIN,V.A.LUSHPA,M.V.GONCHARUK,A.S.ARSENIEV, JRNL AUTH 3 S.A.GONCHARUK,X.WANG,K.S.MINEEV JRNL TITL THE ARCHITECTURE OF TRANSMEMBRANE AND CYTOPLASMIC JRNL TITL 2 JUXTAMEMBRANE REGIONS OF TOLL-LIKE RECEPTORS. JRNL REF NAT COMMUN V. 14 1503 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 36932058 JRNL DOI 10.1038/S41467-023-37042-6 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 3.98.13 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8AR2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1292124455. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 313; 318 REMARK 210 PH : 6.0; 6.0 REMARK 210 IONIC STRENGTH : 50; 160 REMARK 210 PRESSURE : AMBIENT ATM; AMBIENT ATM REMARK 210 SAMPLE CONTENTS : 1000 UM [U-13C; U-15N] PROTEIN, REMARK 210 220 MM [U-2H] DPC, 20 MM REMARK 210 POTASSIUM PHOSPHATE, 4 MM TCEP, REMARK 210 0.05 % W/V SODIUM AZIDE, 1 MM REMARK 210 TSP, 95% H2O/5% D2O; 180 UM [U- REMARK 210 15N] PROTEIN, 40 MM DPC, 30 MM REMARK 210 POTASSIUM PHOSPHATE, 4 MM TCEP, REMARK 210 0.05 % W/V SODIUM AZIDE, 1 MM REMARK 210 TSP, 30 MG/ML DGPG, 100 MM REMARK 210 POTASSIUM CHLORIDE, 95% H2O/5% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 ALIPHATIC CONSTANT TIME; 2D 1H- REMARK 210 13C HSQC AROMATIC; 3D HNCO; 3D REMARK 210 HNCA; 3D HN(CO)CA; 3D HCCH-TOCSY; REMARK 210 3D HCCH-TOCSY CONSTANT TIME; 3D REMARK 210 1H-15N NOESY; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-13C NOESY REMARK 210 ALIPHATIC CONSTANT TIME; 2D CBHD REMARK 210 AROMATIC; 3D HCCH-COSY AROMATIC; REMARK 210 2D CGCO; 2D CGN; 2D 1H-15N IPAP- REMARK 210 HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 3.0, CARA 1.9.7.1, QMDD REMARK 210 3.2, MOLMOL REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 679 73.27 51.29 REMARK 500 9 PHE A 679 -71.89 -63.67 REMARK 500 10 PHE A 679 -177.09 -57.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34752 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF TLR5 TRANSMEMBRANE AND CYTOPLASMIC REMARK 900 JUXTAMEMBRANE REGIONS DBREF 8AR2 A 632 680 UNP O60602 TLR5_HUMAN 632 680 SEQADV 8AR2 MET A 631 UNP O60602 INITIATING METHIONINE SEQRES 1 A 50 MET GLU GLU VAL LEU LYS SER LEU LYS PHE SER LEU PHE SEQRES 2 A 50 ILE VAL CYS THR VAL THR LEU THR LEU PHE LEU MET THR SEQRES 3 A 50 ILE LEU THR VAL THR LYS PHE ARG GLY PHE CYS PHE ILE SEQRES 4 A 50 CYS TYR LYS THR ALA GLN ARG LEU VAL PHE LYS HELIX 1 AA1 MET A 631 PHE A 679 1 49 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1